<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29271568</article-id>
<article-id pub-id-type="pmc">6065257</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38582</article-id>
<article-id pub-id-type="manuscript">NIHMS982017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prader–Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Butler</surname>
<given-names>Merlin G.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2911-0524</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kimonis</surname>
<given-names>Virginia</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dykens</surname>
<given-names>Elisabeth</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gold</surname>
<given-names>June A.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamura</surname>
<given-names>Roy</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Driscoll</surname>
<given-names>Daniel J.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>University of Kansas Medical Center, Kansas City, Kansas
</aff>
<aff id="A2">
<label>2</label>University of California, Irvine, California
</aff>
<aff id="A3">
<label>3</label>Vanderbilt University, Nashville, Tennessee
</aff>
<aff id="A4">
<label>4</label>University of Florida, Gainesville, Florida
</aff>
<aff id="A5">
<label>5</label>University of South Florida, Tampa, Florida
</aff>
<author-notes>
<corresp id="CR1"><bold>Correspondence</bold>: Merlin G. Butler, MD, PhD, FFACMG, Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, Mail Stop 4015, Kansas City, KS 66160. <email>mbutler4@kumc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>176</volume>
<issue>2</issue>
<fpage>368</fpage>
<lpage>375</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38582-->
<abstract id="ABS1">
<p id="P1">We describe the National Institutes of Health rare disease consortium for Prader-Willi syndrome (PWS) developed to address concerns regarding medical care, diagnosis, growth and development, awareness, and natural history. PWS results from errors in genomic imprinting leading to loss of paternally expressed genes due to 15q11-q13 deletion, maternal disomy 15 or imprinting defects. The 8 year study was conducted at four national sites on individuals with genetically confirmed PWS and early-onset morbid obesity (EMO) with data accumulated to gain a better understanding of the natural history, cause and treatment of PWS. Enrollment of 355 subjects with PWS and 36 subjects with EMO began in September 2006 with study completion in July 2014. Clinical, genetic, cognitive, behavior, and natural history data were systematically collected along with PWS genetic subtypes, pregnancy and birth history, mortality, obesity, and cognitive status with study details as important endpoints in both subject groups. Of the 355 individuals with PWS, 217 (61%) had the 15q11-q13 deletion, 127 (36%) had maternal disomy 15, and 11 (3%) had imprinting defects. Six deaths were reported in our PWS cohort with 598 cumulative years of study exposure and one death in the EMO group with 42 years of exposure. To our knowledge, this description of a longitudinal study in PWS represents the largest and most comprehensive cohort useful for investigators in planning comparable studies in other rare disorders. Ongoing studies utilizing this database should have a direct impact on care and services, diagnosis, treatment, genotype–phenotype correlations, and clinical outcomes in PWS.</p>
</abstract>
<kwd-group>
<kwd>genotype–phenotype correlations</kwd>
<kwd>longitudinal natural history study</kwd>
<kwd>mortality</kwd>
<kwd>Prader–Willi syndrome</kwd>
<kwd>PWS genetic subtypes</kwd>
<kwd>rare disease consortium</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>